Cyclooxygenase-2 and kidney failure

Prostaglandins and Other Lipid Mediators

Volumn 98, Issue 3-4, 2012, Pages 86-90

  Rios, Amelia ^b   Vargas Robles, Hilda ^a   Gámez Méndez, Ana Maria ^a   Escalante, Bruno ^b  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

COX 2; Kidney failure; Prostaglandins

Indexed keywords

ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; CAPTOPRIL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GLUCOCORTICOID; LOSARTAN; MESSENGER RNA; MIFEPRISTONE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; SODIUM; SPIRONOLACTONE;

BLOOD PRESSURE; DISEASE ASSOCIATION; EDEMA; ENZYME ACTIVITY; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; PROTEIN EXPRESSION; RENOVASCULAR HYPERTENSION; REVIEW; URINE OSMOLALITY; URINE VOLUME;

ANIMALS; CYCLOOXYGENASE 2; HUMANS; KIDNEY; RENAL INSUFFICIENCY;

EID: 84864463199     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.11.004     Document Type: Review

References (40)

1. D.C. Brater, C. Harris, J.S. Redfern, and B.J. Gertz Renal effects of COX-2-selective inhibitors Am J Nephrol 21 2001 1 15
2. A. Whelton Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors Am J Med 110 2001 33S 42S
3. M. Komhoff, H.J. Grone, T. Klein, H.W. Seyberth, and R.M. Nusing Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function Am J Physiol Renal Physiol 272 1997 F460 F468
4. E.F. Fleming, K. Athirakul, and M.I. Oliverio Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2 Am J Physiol Renal Physiol 275 1998 F955 F961
5. M.C. Thomas, and D.C.H. Harris Renal effects of cyclo-oxygenase-2 inhibition Nephrology 7 2002 281 286
6. F. Catella-Lawson, B. McAdam, and B.W. Morrison Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids J Pharmacol Exp Ther 289 1999 735 741
7. A. Whelton, G. Schulman, and C. Wallemark Effects of celecoxib and naproxen on renal function in the elderly Arch Intern Med 160 2000 1465 1470
8. A. Hartner, M. Goppelt-Struebe, and K.F. Hilgers Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension Hypertension. 31 1998 201 205
9. J.D. Imig Eicosanoid regulation of the renal vasculature Am J Physiol Renal Physiol 279 2000 F965 F981
10. P. Harding, O.A. Carretero, and W.H. Beierwaltes Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics J Hypertens 18 2000 1107 1113
11. T. Kistler, and P.M. Ambühl Renal safety of combined cyclooxygenase 2 (COX-2) inhibitor and angiotensin II receptor blocker administration in mild volume depletion Swiss Med Wkly 131 2001 193 198
12. R. Birck, S. Krzossok, T. Knoll, C. Braun, F.J. van Der Woude, and P. Rohmeiss Preferential COX-2 inhibitor, meloxicam, compromises renal perfusion in euvolemic and hypovolemic rats Exp Nephrol 8 2000 173 180
13. J.E. Dinchuk, B.D. Car, and R.J. Focht Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II Nature 378 1995 406 409
14. M. Kömhoff, J.L. Wang, H.F. Cheng, R. Langenbach, and J.A. Mckanna Harris RC Breyer MD. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development Kidney Int 57 2000 414 422
15. NantelF, E. Meadows, D. Denis, B. Connolly, K.M. Metters, and A. Giaid Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly FEBS Lett 457 1999 475 477
16. H.F. Cheng, J.L. Wang, and M.Z. Zhang Angiotensin II attenuates renal cortical cyclooxygenase-2 expression J Clin Invest 103 1999 953 961
17. M.Z. Zhang, R.C. Harris, and J.A. McKanna Regulation of cyclooxygenase-2 (COX-2) in rat renal cortex by adrenal glucocorticoids and mineralocorticoids Proc Natl Acad Sci U S A 96 1999 15280 15285
18. R.C. Harris MD COX-2 and the Kidney J Cardiovasc Pharmacol 47 2006 S37 S42
19. T.H. Hostetter, J.L. Olson, H.G. Rennke, M.A. Venkatachalam, and B.M. Brenner Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation Am J Physiol 241 1981 F85 F93
20. B.M. Brenner, T.W. Meyer, and T.H. Hostetter Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease N Engl J Med 307 1982 652 659
21. M.J. Dunn Renal Prostaglandins M.J. Dunn, Renal Endocrinology 1983 Williams & Wilkins Baltimore 1 74
22. V.E. Torres, J.C. Romero, C.G. Strong, D.M. Wilson, and V.R. Walker Renal prostaglandin E during acute renal failure Prostaglandins 8 1974 353 360
23. J.L. Wang, H.F. Cheng, S. Shappell, and R.C. Harris A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats Kidney Int 57 2000 2334 2342
24. R. Komers, J.N. Lindsley, T.T. Oyama, and S. Anderson Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats Clin Exp Pharmacol Physiol 34 2007 36 41
25. J.L. Wang, H.F. Cheng, M.Z. Zhang, J.A. McKanna, and R.C. Harris Selective increase of cyclooxygenase-2 expression in a model of renal ablation Am J Physiol 275 1998 F613 F622
26. P.L. Sanchez, L.M. Salgado, N.R. Ferreri, and B. Escalante Effect of cyclooxygenase-2 inhibition on renal function after renal ablation Hypertension 34 1999 848 853
27. J.C. Pelayo, P.F. Shanley, and Glomerular tubular adaptive responses to acute nephron loss in the rat. Effect of prostaglandin synthesis inhibition J Clin Invest 85 1990 1761 1769
28. R. Komers, J.N. Lindsley, and T.T. Oyama Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes J Clin Invest 107 2001 889 898
29. N. Horiba, E. Kumano, T. Watanabe, H. Shinkura, T. Sugimoto, and M. Inoue Subtotal nephrectomy stimulates cyclooxygenase 2 expression and prostacyclin synthesis in the rat remnant kidney Nephron 91 1 2002 134 141
30. D.H. Kang, T. Nakagawa, and L. Feng A role for uric acid in the progression of renal disease J Am Soc Nephrol 13 2002 2888 2897
31. S. Hirose, T. Yamamoto, and L. Feng Expression and localization of cyclooxygenase isoforms and cytosolic phospholipase A2 in anti-Thy-1 glomerulonephritis J Am Soc Nephrol 9 1998 408 416
32. L.C. Martineau, L.I. McVeigh, B.J. Jasmin, and C.R. Kennedy p38 MAP kinase mediates mechanically induced COX-2 and PG EP4 receptor expression in podocytes: implications for the actin cytoskeleton Am J Physiol Renal Physiol 286 2004 F693 F701
33. H. Cheng, X. Fan, Y. Guan, G.W. Moeckel, R. Zent, and R.C. Harris Distinct roles for basal and induced COX-2 in podocyte injury J Am Soc Nephrol 20 2009 1953 1962
34. R. Komers, J. Zdychová, M. Cahová, L. Kazdová, J.N. Lindsley, and S. Anderson Renal cyclooxygenase-2 in obese Zucker (fatty) rats Kidney Int 67 6 2005 2151 2158
35. J. Hernández, H. Astudillo, and B. Escalante Angiotensin II stimulates cyclooxygenase-2 mRNA expression in renal tissue from rats with kidney failure Am J Physiol Renal Physiol 282 2002 F592 F598
36. J. Huang, and H.M. Siragy Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression Endocrinology 150 2009 5557 5565
37. T. Yang, J.M. Park, and L. Arend Low chloride stimulation of prostaglandin E2 release and cyclooxygenase-2 expression in a mouse macula densa cell line J Biol Chem 275 2000 37922 37929
38. H.F. Cheng Harris RC.Cheng HF. Cyclooxygenase-2 expression in cultured cortical thick ascending limb of Henle increases in response to decreased extracellular ionic content by both transcriptional and post-transcriptional mechanisms. Role of p38-mediated pathways J Biol Chem 277 2002 45638 45643
39. L. Wang, P.J. Flannery, P.B. Rosenberg, T.A. Fields, and R.F. Spurney Gq-dependent signaling upregulates COX2 in glomerular podocytes J Am Soc Nephrol 19 2008 2108 2118
40. H.F. Cheng, C.J. Wang, G.W. Moeckel, M.Z. Zhang, J.A. McKanna, and R.C. Harris Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension Kidney Int 62 2002 929 939